Herbert Loong: A very important resource for oncology drug developers globally

Herbert Loong shared a post on X:

“A very important resource for oncology drug developers globally.

Register for “Measuring Toxicity in Reproductive Organs During Oncology Drug Development: An FDA – ASCO Virtual Workshop” – 10/01/2024.”

Source: Herbert Loong/X

Dr. Herbert H. F. Loong holds several prominent positions in oncology. He is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO).

Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).